Three years ago, BSR launched a partnership with Qualcomm Wireless Reach to amplify the outcomes of BSR’s HERproject program in China through mobile technology. Our work together focused on enhancing HERhealth, the pillar of HERproject that aims to empower low-income women working in global supply chains to take charge of their health.
Through this collaboration, we developed a mobile app to digitize the HERhealth curriculum so that workers could conveniently access health information...
Did you know of 7,000 rare diseases, only 5% have treatments available?
On July 18th, Shire invited professionals local to Cambridge, MA to participate in Rare in Kendall Square: Collaborating to Advance Innovation in Rare Disease. Over 200 attendees gathered to network and weigh in on a panel discussion centered around the idea that partnerships can advance treatment options.
“Our fight against rare diseases cannot be waged alone – unique partnership models are critical,” said Flemming Ornskov, M.D., M.P.H. and CEO of Shire.
Our voice is part of the foundation of how we connect with each other. We voice our needs and share our ideas and feelings. It’s how we’re heard. Having a “voice” is fundamental to being an individual.
Imagine that a doctor could fully examine a patient’s heart, from all angles, before a single incision is made. Or see real patient data as a hologram: zooming in on troublesome areas, enlarging areas of concern. If a tumor is spotted, a doctor “walks” around the area, examining it on all sides.
Following the G20, Joerg Reinhardt, Chairman of the Novartis Board of Directors, reflects on how to fight rising antimicrobial resistance
ZURICH, Switzerland, July 20, 2017/3BL Media/ – Two weeks ago, G20 leaders committed to working together to address one of the world’s most pressing and perplexing security threats: antimicrobial resistance (AMR) – a fierce and evolving adversary against which conventional therapeutic weapons are of no use.
In two articles in the Lancet Infectious Diseases, the Novartis Foundation and its partners review the historic and future innovations and game-changing strategies in leprosy elimination, calling for a global effort to make leprosy history.
July 10, 2017 /3BL Media/ - On July 7th, 2017 the Novartis Foundation and its partners published two articles that call for a global effort to make leprosy history. The reviews have been published in the Lancet Infectious Diseases, a leading journal in infectious diseases.[i]
The World Health Assembly (WHA) is the world's highest health policy setting body. Its main tasks are to decide major public health policy questions, approve the World Health Organization’s work programme and budget, and elect its Director General. Together with our UN partner WSSCC and Wateraid, Essity hosted an event focusing on “Hygiene and Health throughout the Life Course”.
To speed the search to cure diseases, genomics leader HudsonAlpha Institute for Biotechnology generates enormous amounts of DNA data in its research labs. To tackle petabytes of information, they partnered with HPE to design flexible, high-performance systems and connectivity solutions that support intensive research, collaboration, and analysis. The powerful technology is helping HudsonAlpha’s scientists deliver on the tremendous promise of genomics to drive medical breakthroughs including ground-breaking research into Zika and other deadly diseases.